$0.588
-0.032[-5.16%]
At close: Apr 17
$0.588
0[0.00%]
After Hours: 7:05PM EDT
VBI Vaccines
(NASDAQ:VBIV)VBI Vaccines Stock (NASDAQ:VBIV), Analyst Ratings, Price Targets, Predictions
VBI Vaccines Inc has a consensus price target of $6, established from looking at the 4 latest analyst ratings. The last 3 analyst ratings were released from Raymond James, Raymond James, and Raymond James on April 13, 2023, November 11, 2022, and August 9, 2022. With an average price target of $4.33 between Raymond James, Raymond James, and Raymond James, there's an implied 636.96% upside for VBI Vaccines Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Raymond James
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for VBI Vaccines
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/13/2023 | VBIV | Buy Now | VBI Vaccines | $0.59 | 920.41% | Raymond James | Steven Seedhouse | $60 → $6 | Maintains | Outperform | Get Alert |
| 11/11/2022 | VBIV | Buy Now | VBI Vaccines | $0.59 | 240.14% | Raymond James | Steven Seedhouse | $150 → $60 | Downgrade | Strong Buy → Outperform | Get Alert |
| 08/09/2022 | VBIV | Buy Now | VBI Vaccines | $0.59 | 750.34% | Raymond James | Steven Seedhouse | $180 → $150 | Maintains | Strong Buy | Get Alert |
| 03/08/2022 | VBIV | Buy Now | VBI Vaccines | $0.59 | 920.41% | Raymond James | Steven Seedhouse | $270 → $180 | Maintains | Strong Buy | Get Alert |
FAQ
What is the target price for VBI Vaccines (VBIV)?
The latest price target for VBI Vaccines (NASDAQ: VBIV) was reported by Raymond James on April 13, 2023. The analyst firm set a price target for $6.00 expecting VBIV to rise to within 12 months (a possible 920.41% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for VBI Vaccines (VBIV)?
The latest analyst rating for VBI Vaccines (NASDAQ: VBIV) was provided by Raymond James, and VBI Vaccines maintained their outperform rating.
When was the last upgrade for VBI Vaccines (VBIV)?
There is no last upgrade for VBI Vaccines.
When was the last downgrade for VBI Vaccines (VBIV)?
The last downgrade for VBI Vaccines Inc happened on November 11, 2022 when Raymond James changed their price target from $5 to $2 for VBI Vaccines Inc.
When is the next analyst rating going to be posted or updated for VBI Vaccines (VBIV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of VBI Vaccines, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for VBI Vaccines was filed on April 13, 2023 so you should expect the next rating to be made available sometime around April 13, 2024.
Is the Analyst Rating VBI Vaccines (VBIV) correct?
While ratings are subjective and will change, the latest VBI Vaccines (VBIV) rating was a maintained with a price target of $60.00 to $6.00. The current price VBI Vaccines (VBIV) is trading at is $0.59, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.